Cowen Starts Immune Design (IMDZ) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Alibaba falls on China AI capex report; Citi says selloff is premature
Immune Design (IMDZ) Tops Q1 EPS by 8c
May 14, 2015 7:00 AM EDTImmune Design (NASDAQ: IMDZ) reported Q1 EPS of ($0.56), $0.08 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $1.9 million versus the consensus estimate of $1.3 million.
For earnings history and earnings-related data on Immune Design (IMDZ) click here.
... More